Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,562.48
(
-0.75%
)
US TECH 100
23,296.40
(
-1.03%
)
Dow Jones
46,292.45
(
-0.81%
)
Brent Oil
106.62
(
-0.42%
)
Bitcoin
68,551.27
(
-0.45%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DragonBits

Send PM Follow Ignore
Followers 5
Posts 2508
Boards Moderated 0
Alias Born 02/22/2008

DragonBits

Re: ThomasS post# 15319

Friday, 11/21/2008 12:37:25 AM

Friday, November 21, 2008 12:37:25 AM

Post# of 19309
It's always a concern when a company returns a drug to the developer.

I don't recall if there were any ATRYN sales, and I don't know how profitable LEO is. Perhaps they felt they just couldn't afford to fund DIC trials. These tough economic times have changed a lot of business arrangements.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today